Lynn L. Bergeson and Michael F. Cole, “NanoBioConvergence—Emerging Diagnostic and Therapeutic Applications,” Bioprocessing & Biopartnering 2006: Featuring NanoBiotechnology, 2006.

Many people regard nanotechnology as a “stand-alone” technology. While the technology itself is of great interest, the most intriguing aspect of nanotechnology is that it is increasingly being utilised as an integral part of a more complicated convergence matrix. The intersection of nanotechnology, biotechnology, information technology, and cognitive science, otherwise referred to as ‘NBIC convergence’, is leading to the development of nanobiotechnology products that promise to change radically the provision of healthcare in the decades ahead.